Suppr超能文献

增强型靶向基因转导:通过还原型二硫键连接的多个适体修饰的 AAV2 载体。

Enhanced Targeted Gene Transduction: AAV2 Vectors Conjugated to Multiple Aptamers via Reducible Disulfide Linkages.

机构信息

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory for Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Life Sciences, and Aptamer Engineering Center of Hunan Province, Hunan University , Changsha, Hunan 410082, China.

Center for Research at Bio/Nano Interface, Department of Chemistry and Department of Physiology and Functional Genomics, University Health Cancer Center, UF Genetics Institute and McKnight Brain Institute, University of Florida , Gainesville, Florida 32611-7200, United States.

出版信息

J Am Chem Soc. 2018 Jan 10;140(1):2-5. doi: 10.1021/jacs.7b08518. Epub 2017 Dec 27.

Abstract

Enhanced targeted gene transduction by AAV2 vectors is achieved by linking the vector to multiple sgc8 aptamers, which are selective for cell membrane protein PTK7. Aptamer molecules are conjugated to multiple sites on a DNA dendrimer (G-sgc8), which is then linked to AAV2 via a dithiobis(succinimidyl propionate) cross-linker containing a disulfide group, which can facilitate the release of AAV2 vectors by reaction with the reduced form of intracellular glutathione. The G-sgc8-AAV2 vectors showed a 21-fold enhancement in binding affinity and an enhanced ability to protect sgc8 aptamers against nuclease degradation to cells expressing PTK7 compared to single aptamer-AAV2 conjugates. The transduction efficiency was tested by loading AAV2 with the gene for green fluorescent protein. Therefore, this modified recombinant vector is an attractive and promising tool for targeted biomedical applications.

摘要

通过将载体与多个针对细胞膜蛋白 PTK7 的 sgc8 适体连接,实现了 AAV2 载体的增强靶向基因转导。适体分子连接到 DNA 树枝状大分子(G-sgc8)的多个位点上,然后通过含有二硫键的二硫代琥珀酰亚胺基丙酸(Dithiobis(succinimidyl propionate))交联剂与 AAV2 连接,该二硫键可以通过与细胞内还原型谷胱甘肽反应促进 AAV2 载体的释放。与单个适体-AAV2 缀合物相比,G-sgc8-AAV2 载体与表达 PTK7 的细胞的结合亲和力提高了 21 倍,并且能够增强保护 sgc8 适体免受核酸酶降解的能力。通过装载携带绿色荧光蛋白基因的 AAV2 来测试转导效率。因此,这种改良的重组载体是一种有吸引力和有前途的靶向生物医学应用工具。

相似文献

引用本文的文献

3
Recent progress of aptamer‒drug conjugates in cancer therapy.适体-药物偶联物在癌症治疗中的最新进展。
Acta Pharm Sin B. 2023 Apr;13(4):1358-1370. doi: 10.1016/j.apsb.2023.01.017. Epub 2023 Jan 26.
8
Oligonucleotide-Based Therapies for Renal Diseases.基于寡核苷酸的肾脏疾病治疗方法
Biomedicines. 2021 Mar 16;9(3):303. doi: 10.3390/biomedicines9030303.
9
Aptamer-based targeted therapy.基于适配体的靶向治疗。
Adv Drug Deliv Rev. 2018 Sep;134:65-78. doi: 10.1016/j.addr.2018.08.005. Epub 2018 Aug 17.

本文引用的文献

1
Adeno-associated virus-mediated cancer gene therapy: current status.腺相关病毒介导的癌症基因治疗:现状
Cancer Lett. 2015 Jan 28;356(2 Pt B):347-56. doi: 10.1016/j.canlet.2014.10.045. Epub 2014 Nov 10.
10
Controlled assembly of dendrimer-like DNA.树枝状DNA的可控组装
Nat Mater. 2004 Jan;3(1):38-42. doi: 10.1038/nmat1045. Epub 2003 Dec 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验